VenomAid Diagnostics

Kongens Lyngby, Denmark

VenomAid Diagnostics is a company that provides clinically rapid diagnostic tests for snakebite envenoming.

$800K raised

Jan 2024

Seed

Clinical Trials Health Diagnostics

Top Investors

Novo Nordisk Foundation Good Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about VenomAid Diagnostics

How much funding has VenomAid Diagnostics raised?

VenomAid Diagnostics has raised $800K in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are VenomAid Diagnostics's investors?

VenomAid Diagnostics's investors include Novo Nordisk Foundation, Good Ventures.

Where is VenomAid Diagnostics headquartered?

VenomAid Diagnostics is headquartered in Kongens Lyngby, Denmark.

What does VenomAid Diagnostics do?

VenomAid Diagnostics is a company that provides clinically rapid diagnostic tests for snakebite envenoming.

What stage is VenomAid Diagnostics at?

VenomAid Diagnostics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2024.

MLA

"VenomAid Diagnostics — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/venomaid-diagnostics. Accessed July 2, 2026.

APA

VCBacked. (2024). VenomAid Diagnostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/venomaid-diagnostics

Wikipedia (cite web)

{{cite web |title=VenomAid Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/venomaid-diagnostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2024.